Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02690545
Title Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.